AVEO Oncology
AVEO
#7099
Rank
NZ$0.90 B
Marketcap
NZ$25.96
Share price
0.00%
Change (1 day)
175.69%
Change (1 year)

AVEO Oncology (AVEO) - Net assets

Net assets on the balance sheet as of September 2022 : NZ$49.93 Million

According to AVEO Oncology 's latest financial reports the company has NZ$49.93 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AVEO Oncology - Net assets on balance sheet (from 2008 to 2022)

Net assets by year

Year Net assets Change
2021-12-31$NZ$67.15 M37.29%
2020-12-31$NZ$48.91 M121.9%
2019-12-31$NZ$22.04 M-154.31%
2018-12-31$-NZ$40.6 Million-29.28%
2017-12-31$-NZ$57.4 Million1967.49%
2016-12-31$-NZ$2.78 Million-111.03%
2015-12-31$NZ$25.17 M-4.29%
2014-12-31$NZ$26.29 M-69.1%
2013-12-31$NZ$85.1 M-41.14%
2012-12-31$NZ$0.14 B-49.52%
2011-12-31$NZ$0.28 B207.89%
2010-12-31$NZ$93.02 M-657.16%
2009-12-31$-NZ$16.7 Million-92.47%
2008-12-31$-NZ$0.23 Billion72.52%
2007-12-31$-NZ$0.13 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Biogen
BIIB
NZ$31.51 B 63,021.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$53.58 B 107,224.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
NZ$0.38 B 668.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$32.19 B 64,382.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$41.28 B 82,586.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$16.65 B 33,247.20%๐Ÿ‡บ๐Ÿ‡ธ USA